Andras Garami Selected Research

N- (4- (6- (4- trifluoromethylphenyl)pyrimidin- 4- yloxy)benzothiazol- 2- yl)acetamide

11/2017	Transient Receptor Potential Vanilloid 1 Antagonists Prevent Anesthesia-induced Hypothermia and Decrease Postincisional Opioid Dose Requirements in Rodents.
5/2008	Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andras Garami Research Topics

Disease

7	Hyperthermia 01/2022 - 05/2008
6	Hypothermia 09/2021 - 01/2012
4	Inflammation (Inflammations) 01/2022 - 01/2015
4	Fever (Fevers) 01/2022 - 01/2015
3	Pain (Aches) 01/2010 - 05/2008
2	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 10/2018
2	Sepsis (Septicemia) 01/2021 - 01/2012
2	Wounds and Injuries (Trauma) 01/2019 - 03/2018
2	Burns 01/2019 - 03/2018
1	Pneumonia (Pneumonitis) 03/2022
1	Respiratory Insufficiency (Respiratory Failure) 03/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2022
1	Atherosclerosis 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Infections 01/2019
1	Necrosis 03/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2018
1	Ulcer 12/2017
1	Hemorrhage 12/2017
1	Hyperalgesia 11/2017
1	Hypersensitivity (Allergy) 11/2017
1	Hyperbilirubinemia 01/2015
1	Hyperkinesis 11/2014
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2012
1	Neoplasms (Cancer) 05/2008
1	Acute Pain 05/2008

Drug/Important Bio-Agent (IBA)

4	LipopolysaccharidesIBA 01/2022 - 01/2015
2	EndotoxinsIBA 01/2022 - 01/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022 - 01/2018
2	Protons (Proton)IBA 01/2020 - 01/2010
2	Dinoprostone (PGE2)FDA Link 01/2018 - 01/2018
2	Analgesics (Analgesic Drugs)IBA 12/2017 - 11/2017
2	N- (4- (6- (4- trifluoromethylphenyl)pyrimidin- 4- yloxy)benzothiazol- 2- yl)acetamideIBA 11/2017 - 05/2008
1	Cholecystokinin B ReceptorIBA 01/2022
1	Cholecystokinin (Pancreozymin)IBA 01/2022
1	YM 022IBA 01/2022
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022
1	CholesterolIBA 01/2022
1	sodium sulfideIBA 09/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 09/2021
1	GYY 4137IBA 09/2021
1	Macrophage Migration-Inhibitory FactorsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2018
1	SteroidsIBA 03/2018
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 03/2018
1	ZincIBA 03/2018
1	SilverIBA 03/2018
1	PyrogensIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	CytokinesIBA 01/2018
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2017
1	Proton Pump InhibitorsIBA 12/2017
1	Morphine (MS Contin)FDA LinkGeneric 11/2017
1	Opioid Analgesics (Opioids)IBA 11/2017
1	ABT 102IBA 11/2017
1	BilirubinIBA 01/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	Amino Acids FDA Link 11/2014
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 11/2014
1	AMG2850IBA 03/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Capsaicin (Zostrix)FDA Link 01/2010
1	TRPV Cation ChannelsIBA 05/2008

Therapy/Procedure

4	Induced Hypothermia 10/2021 - 01/2015
3	Therapeutics 03/2018 - 09/2009
1	Noninvasive Ventilation 03/2022
1	Induced Hyperthermia (Thermotherapy) 01/2022
1	Antibiotic Prophylaxis 01/2019
1	Biological Therapy 03/2018
1	Anesthesia 11/2017
1	General Anesthesia 11/2017
1	Intravenous Administration 01/2015
1	Intravenous Infusions 11/2014
1	Ligation 01/2012
1	Punctures 01/2012